Axel S. Merseburger路 @amerseburger 路 X路路 2 days agoScore90
Body 路 original
KEYNOTE-866 did not show EFS not OS. Great presentation 馃憦馃徏by Prof Jens Bedke #ESMO26 @OncoAlert @Uromigos @urotoday @Uroweb @DGUrologie @high5md
928 views 路 19 likes 路 14 reposts 路 1 reply
Conference abstracts
4735Omatched by Proffered paper 1: Genitourinary tumour, renal and urothelial
Perioperative pembrolizumab (pembro) or placebo (pbo) + neoadjuvant cisplatin (cis) and gemcitabine (gem) in participants (pts) with muscle-invasive bladder cancer (MIBC): the double-blind, phase 3 KEYNOTE-866 study
https://esmocongress.esmo.orgReplies in this thread
- Stefania Colasanti@Stefani19753108
@amerseburger @OncoAlert @Uromigos @urotoday @Uroweb @DGUrologie @high5md @cnsternberg 馃憦馃憦馃憦 Prof Jens Bedke 馃憦馃憦馃憦! Great job in Madrid @cnsternberg @amerseburger @OncoAlert @Uromigos @urotoday @Uroweb @DGUrologie @high5md 馃檶馃檶馃檶馃檶
Source: Axel S. Merseburger 路 x.com